| Authors | Torben Lykke Sørensen, Henrik Kemp |
| Journal | Acta ophthalmologica
(Acta Ophthalmol)
Vol. 89
Issue 1
Pg. e97
(Feb 2011)
ISSN: 1755-3768 [Electronic] England |
| PMID | 20384603
(Publication Type: Letter)
|
| Chemical References |
- Angiogenesis Inhibitors
- Antibodies, Monoclonal
- Antibodies, Monoclonal, Humanized
- VEGFA protein, human
- Vascular Endothelial Growth Factor A
- Ranibizumab
|
| Topics |
- Aged
- Aged, 80 and over
- Angiogenesis Inhibitors
(therapeutic use)
- Antibodies, Monoclonal
(therapeutic use)
- Antibodies, Monoclonal, Humanized
- Choroidal Neovascularization
(drug therapy)
- Female
- Follow-Up Studies
- Humans
- Macular Degeneration
(drug therapy)
- Male
- Middle Aged
- Ranibizumab
- Treatment Outcome
- Vascular Endothelial Growth Factor A
(antagonists & inhibitors)
- Vision, Low
(drug therapy)
- Visual Acuity
(physiology)
|
